SCHEMBL12776985

SCHEMBL12776985

CC(C)(C)c1ccc2oc(-c3cc(-c4cccc5ccccc45)c4ccc5c(-c6cccc7ccccc67)cc(-c6cccc7ccccc67)c6ccc3c4c65)nc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.53
▸ ALDH1A1 P00352 5/20 0.53
▸ HPGD P15428 4/20 0.53
▸ HSD17B10 Q99714 3/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ ESR1 P03372 5/20 0.47
▸ ESR2 Q92731 5/20 0.47
▸ TP53 P04637 4/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ NPC1 O15118 5/20 0.42
▸ RAB9A P51151 5/20 0.42
▸ GFER P55789 1/20 0.42
▸ KDM4E B2RXH2 5/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12776998 0.90 MAPT (0.43) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL28618111 0.89 MAPT (0.65) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL12777027 0.87 MAPT (0.52) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL12777088 0.85 MAPT (0.38) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL12777085 0.85 MAPT (0.47) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL12776991 0.85 ALDH1A1 (0.56) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL12777155 0.84 NPC1 (0.41) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL9890965 0.83 ALDH1A1 (0.56) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL12777067 0.83 NPC1 (0.48) MAPTALDH1A1HPGDHSD17B10TP53
SCHEMBL12777017 0.82 NPC1 (0.55) MAPTALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7901794-B2 Material for light-emitting element and light emitting element TORAY INDUSTRIES, INC. (JP) 2011-03-08 — — US disclosed
US-7901794-B2 Material for light-emitting element and light emitting element TORAY INDUSTRIES, INC. (JP) 2011-03-08 — — US disclosed
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2009-03-12 — — US disclosed
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT PYM1, CRY1, S100A10 MAPT 2121/4885ALDH1A1 2046/4885HPGD 2445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback